BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37039262)

  • 1. Prognostic assessment in patients operated for brain metastasis from systemic tumors.
    Grossenbacher B; Lareida A; Moors S; Roth P; Kulcsar Z; Regli L; Le Rhun E; Weller M; Wolpert F
    Cancer Med; 2023 Jun; 12(11):12316-12324. PubMed ID: 37039262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
    Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
    World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Navigating Post-Operative Outcomes: A Comprehensive Reframing of an Original Graded Prognostic Assessment in Patients with Brain Metastases.
    Goldberg M; Mondragon-Soto MG; Dieringer L; Altawalbeh G; Pöser P; Baumgart L; Wiestler B; Gempt J; Meyer B; Aftahy AK
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
    Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC
    Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
    Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan.
    Deguchi S; Nakasu Y; Sakaida T; Akimoto J; Tanahashi K; Natsume A; Takahashi M; Okuda T; Asakura H; Mitsuya K; Hayashi N; Narita Y
    Int J Clin Oncol; 2020 Nov; 25(11):1995-2005. PubMed ID: 32648133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
    Nieder C; Hess S; Lewitzki V
    Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome.
    Griguolo G; Dieci MV; Giarratano T; Giorgi CA; Orvieto E; Ghiotto C; Berti F; Della Puppa A; Falci C; Mioranza E; Tasca G; Milite N; Miglietta F; Scienza R; Conte P; Guarneri V
    J Neurooncol; 2017 Jan; 131(2):369-376. PubMed ID: 27853958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy.
    Liu S; Chen P; Liu YW; Gu XN; Qiu XG; Li B
    Chin Med J (Engl); 2018 May; 131(10):1206-1213. PubMed ID: 29722340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases.
    Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
    J Clin Oncol; 2012 Feb; 30(4):419-25. PubMed ID: 22203767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score.
    Jakola AS; Gulati S; Nerland US; Solheim O
    J Neurooncol; 2011 Dec; 105(3):573-81. PubMed ID: 21660540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    Hayashi N; Takahashi H; Hasegawa Y; Higuchi F; Takahashi M; Makino K; Takagaki M; Akimoto J; Okuda T; Okita Y; Mitsuya K; Hirashima Y; Narita Y; Nakasu Y;
    BMC Cancer; 2017 Jun; 17(1):397. PubMed ID: 28577359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery.
    Joshi RS; Hirshman BR; Ali MA; Alattar A; Carroll K; Nagano O; Aiyama H; Serizawa T; Yamamoto M; Chen CC
    World Neurosurg; 2019 Jan; 121():e747-e754. PubMed ID: 30308343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nine prognostic scores in patients with brain metastases of breast cancer receiving radiotherapy of the brain.
    Laakmann E; Riecke K; Goy Y; Kersten JF; Krüll A; Müller V; Petersen C; Witzel I
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):325-32. PubMed ID: 26424693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases.
    Dyer MA; Kelly PJ; Chen YH; Pinnell NE; Claus EB; Lee EQ; Weiss SE; Arvold ND; Lin NU; Alexander BM
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e479-86. PubMed ID: 22704705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.
    Park YH; Kim TH; Jung SY; Kim YE; Bae JM; Kim YJ; Choi JH; Lee NK; Moon SH; Kim SS; Shin KH; Kim JY; Kim DY; Cho KH
    J Korean Med Sci; 2013 Feb; 28(2):205-12. PubMed ID: 23400308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
    Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
    J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.